ANG Lifesciences India Limited (BOM:540694)

Market Cap	324.11M
Revenue (ttm)	922.09M
Net Income (ttm)	-122.05M
Shares Out	13.06M
EPS (ttm)	-9.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,327
Average Volume	6,690
Open	25.15
Previous Close	25.15
Day's Range	23.90 - 26.39
52-Week Range	21.03 - 44.63
Beta	-0.13
RSI	33.99
Earnings Date	Feb 13, 2026

About ANG Lifesciences India

ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and ...

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Employees: 412
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540694

Financial Performance

In 2024, ANG Lifesciences India's revenue was 928.47 million, a decrease of -36.45% compared to the previous year's 1.46 billion. Losses were -124.13 million, 22.4% more than in 2023.